tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mankind Pharma Reports No Share Dematerialisation Requests for Q3 2025

Story Highlights
Mankind Pharma Reports No Share Dematerialisation Requests for Q3 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Mankind Pharma Ltd. ( (IN:MANKIND) ) has provided an announcement.

Mankind Pharma Limited has announced that it has not received any requests for dematerialisation or rematerialisation of shares for the quarter ending September 30, 2025. This update, certified by KFin Technologies Limited, aligns with the company’s adherence to SEBI (Depositories and Participants) Regulations, 2018, ensuring transparency and compliance in its share management practices.

More about Mankind Pharma Ltd.

Average Trading Volume: 17,778

Technical Sentiment Signal: Hold

Current Market Cap: 1006.6B INR

For detailed information about MANKIND stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1